| Thanks to SoCalBio Weekly Update Sponsor |
Coming in 2011
SoCalBio Presents
|  | Exploring opportunities and challenges of cloud computing in the highly regulated biotech and medical device industries.
|
Join SoCalBio Biomedical Entrepreneur Alfred Mann | Join well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
| RSVP Now
| August 26, 4:00 to 7:00 PM
SoCalBio Networking Forum in Ventura County
Opportunities and Competitive Strategies
in the Orthopedic Market
Market Dynamics * Growth Drivers * Competition * New Technologies
 Speakers G. K. Kannan, Global Marketing, Baxter Bioscience Dale Klous, VP, Clinical Operations,
RCRI, Inc.
Ken Mariash, Group Manager, Strategy, Baxter Bioscience Vineet Sarin, PhD, President, Kinamed
|
| Grants | Twenty Greater Los Angeles-Based Companies Attract $4.8 Million in New NIH
SBIR/STTR Funding During 2010
 The list of winners includes familiar faces such as Physical Optics Corporation (Torrance), Gene Fluidics (Monterey Park) and Innosese (Torrance). It also includes newcomers such as Biostruxs (Thousand Oaks) and Synedgen (Claremont)... Click here to see the list |
| Under the Spotlight | Agendia (Irvine)
Cancer Testing Co. Expands Lab, HQ Space; Plans Diversified Tests to Stave Off Competition
 Cancer testing company Agendia BV has expanded into a larger Orange County laboratory. Earlier this month,
Agendia, which is headquartered in Amsterdam, moved its U.S. base to Irvine from Huntington Beach. Agendia's laboratory and headquarters now are in a 17,000-square-foot, two-story building at 22 Morgan near Bake Parkway and Jeronimo Road in the Irvine Spectrum. The space includes a first-floor laboratory and corporate offices on the second floor.... Read more at OC Business Journal |
| Opinion | Virtual Biotechs Are Here to Stay
Multiple events have conspired this past decade to force change upon the biopharmaceutical industry. Significant outsourcing by Big Pharma and virtual biotechs appear here to stay. The key to making a virtual biotech succeed is a superior leadership team able to select the right CROs and manage those relationships to build enough trust so they can perform their work with minimal supervision ... Read Article at Seeking Alpha |
Analysis
| Medical Device Errors Cost US $1.1 Billion Annually
A study by
Milliman, an actuarial consulting firm, commissioned by the Society of Actuaries has concluded that errors from mechanical complication of devices, implants, or grafts cost the US economy over $1.1 billion in 2008. The point of the study was to calculate the total amount medical errors cost that year (that number came in at $19.5 billion) with medical devices causing the 3rd highest categorical total (pressure ulcers were #1 with a cost of just under $4 Billion)... Access Study Here |
| Recent Headlines | Device Clearance:
Drug Approval:
Corporate Social Responsibility:
|
Jobs Available
| - LA Basin Clinical and Translational Science Institute (Los Angeles)
- UK Trade & Investment USA (Los Angeles)
|
| About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
| |
|
